SK

Surendra Kumar Tripathi

Active Director Director DIN 09016222
DIN 09016222 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Surendra Kumar Tripathi

Data last updated:

Surendra Kumar Tripathi is a Director at Castlemed Life Sciences Private Limited (since 2025), Director at Lanceli Lifesciences Private Limited (since 2024) and Designated Partner at Hdfs Biotech Llp (since 2020). The companies operate in Pharma, Biotechnology and Trading. Earlier, Surendra Kumar Tripathi was a Director at Hdfs Pharmaceuticals Private Limited (2022–2025).

DIN 09016222
Primary Designation Director
Industry Pharma
First Appointment 31 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Sep 20252025Active
Lanceli Lifesciences Private Limited U46497UP2024PTC212709
Director29 Nov 20242024Active
Hdfs Biotech Llp AAV-3019
Designated Partner31 Dec 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hdfs Pharmaceuticals Private Limited U51909UP2022PTC175891
Director29 Dec 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hdfs Biotech Llp
Castlemed Life Sciences Private Limited
Lanceli Lifesciences Private Limited
Hdfs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Surendra Kumar Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Kumar Tripathi

Surendra Kumar Tripathi currently holds 3 directorships: Castlemed Life Sciences Private Limited (Director, since 12 Sep 2025); Lanceli Lifesciences Private Limited (Director, since 29 Nov 2024); Hdfs Biotech Llp (Designated Partner, since 31 Dec 2020).

Surendra Kumar Tripathi was first appointed on 31 Dec 2020 as Designated Partner at Hdfs Biotech Llp. The most recent appointment on record is 12 Sep 2025 at Castlemed Life Sciences Private Limited.

Surendra Kumar Tripathi held 1 earlier board appointment: Hdfs Pharmaceuticals Private Limited (Director, 29 Dec 2022 to 30 Mar 2025).

The current boards of Surendra Kumar Tripathi's companies include Dhawal Prajapati (Castlemed Life Sciences Private Limited), Ashutosh Tripathi (Lanceli Lifesciences Private Limited), Kripa Shanker Tripathi (Lanceli Lifesciences Private Limited), Habib Ahmad (Hdfs Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available